| Bioactivity | (rel)-Tivantinib is a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET. (rel)-Tivantinib has two novel targets, GSK3α and GSK3β, which play an important role in the cellular mechanism of non-small cell lung cancer (NSCLC)[1]. |
| Name | (rel)-Tivantinib |
| CAS | 905853-99-8 |
| Formula | C23H19N3O2 |
| Molar Mass | 369.42 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Remsing Rix LL, et al. GSK3 alpha and beta are new functionally relevant targets of tivantinib in lung cancer cells. ACS Chem Biol. 2014 Feb 21;9(2):353-8. |
(rel)-Tivantinib
CAS: 905853-99-8 F: C23H19N3O2 W: 369.42
(rel)-Tivantinib is a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET. (rel)-Tivantinib has
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.